Karyopharm Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $18.1M | $180.4M | $49.7M |
| FY2017 | $50.8M | $180.3M | $69.0M |
| FY2018 | $158.0M | $341.2M | $118.0M |
| FY2019 | $245.2M | $295.0M | $128.9M |
| FY2020 | $262.5M | $313.1M | $85.9M |
| FY2021 | $385.0M | $305.3M | $190.5M |
| FY2022 | $374.8M | $358.2M | $135.2M |
| FY2023 | $376.6M | $240.4M | $52.2M |
| FY2024 | $350.4M | $164.4M | $62.5M |
| FY2025 | $401.3M | $108.4M | $60.5M |